The Harvard Drug Group 2023-05-17 Health moderate FDA
Health · FDA · Recall #FDA-D-0570-2023
Gabapentin Tablets, USP 600 mg, packaged in Cartons of 100 tablets (10 tablets per… Recall
Issued May 17, 2023 · The Harvard Drug Group
In May 2023, The Harvard Drug Group recalled the Gabapentin Tablets, USP 600 mg, packaged in Cartons of 100 tablets (10 tablets per…, a moderate health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Product mixup: one foreign tablet found in product.
What you should do
- 1 Stop using Gabapentin Tablets, USP 600 mg, packaged in Cartons of 100 tablets (10 tablets per… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact The Harvard Drug Group to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- The Harvard Drug Group
- Category
- Health
- Recall date
- May 17, 2023
- Units affected
- Not reported
- Sold at
- USA Nationwide
- Recall number
- FDA-D-0570-2023
- Made in
- United States
- Issuing agency
- FDA
In context
- The Harvard Drug Group has 2 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 903rd Health recall we've logged in 2023.